Fidelity Investments’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Sell |
87,344
-13,331
| -13% | -$27.1K | ﹤0.01% | 3352 |
|
|
2025
Q1 | $164K | Buy |
100,675
+19,295
| +24% | +$31.5K | ﹤0.01% | 3331 |
|
|
2024
Q4 | $149K | Buy |
81,380
+54,119
| +199% | +$99K | ﹤0.01% | 3383 |
|
|
2024
Q3 | $158K | Buy |
27,261
+21,462
| +370% | +$124K | ﹤0.01% | 3277 |
|
|
2024
Q2 | $46.9K | Sell |
5,799
-6,612
| -53% | -$53.4K | ﹤0.01% | 3645 |
|
|
2024
Q1 | $172K | Buy |
12,411
+237
| +2% | +$3.29K | ﹤0.01% | 3081 |
|
|
2023
Q4 | $74.5K | Sell |
12,174
-3,271
| -21% | -$20K | ﹤0.01% | 3335 |
|
|
2023
Q3 | $72.1K | Buy |
15,445
+13,336
| +632% | +$62.3K | ﹤0.01% | 3217 |
|
|
2023
Q2 | $11.3K | Buy |
2,109
+1,390
| +193% | +$7.45K | ﹤0.01% | 4105 |
|
|
2023
Q1 | $7.08K | Sell |
719
-565
| -44% | -$5.56K | ﹤0.01% | 4262 |
|
|
2022
Q4 | $24K | Sell |
1,284
-86
| -6% | -$1.61K | ﹤0.01% | 3717 |
|
|
2022
Q3 | $28K | Buy |
1,370
+848
| +162% | +$17.3K | ﹤0.01% | 3708 |
|
|
2022
Q2 | $11K | Buy |
522
+202
| +63% | +$4.26K | ﹤0.01% | 4086 |
|
|
2022
Q1 | $14K | Buy |
320
+314
| +5,233% | +$13.7K | ﹤0.01% | 4130 |
|
|
2021
Q4 | $0 | Sell |
6
-55
| -90% | – | ﹤0.01% | 4659 |
|
|
2021
Q3 | $5K | Buy |
61
+24
| +65% | +$1.97K | ﹤0.01% | 3799 |
|
|
2021
Q2 | $4K | Buy |
37
+27
| +270% | +$2.92K | ﹤0.01% | 3782 |
|
|
2021
Q1 | $1K | Sell |
10
-22,911
| -100% | -$2.29M | ﹤0.01% | 3842 |
|
|
2020
Q4 | $2.43M | Sell |
22,921
-41,296
| -64% | -$4.39M | ﹤0.01% | 2366 |
|
|
2020
Q3 | $8.94M | Buy |
64,217
+63,630
| +10,840% | +$8.86M | ﹤0.01% | 1869 |
|
|
2020
Q2 | $190K | Buy |
+587
| New | +$190K | ﹤0.01% | 2635 |
|
|
2018
Q4 | – | Sell |
-33,292
| Closed | -$2.22M | – | 3828 |
|
|
2018
Q3 | $2.22M | Buy |
+33,292
| New | +$2.22M | ﹤0.01% | 2346 |
|